Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
Correction: Tognetti et al. Pattern Analysis of Benign and Malignant Atypical Melanocytic Skin Lesions of Palms and Soles: Variations of Dermoscopic Features According to Anatomic Site and Personal Experience. <i>Life</i> 2024, <i>14</i>, 659.
AuteursTognetti L, Cartocci A, Moscarella E, Lallas A, Dika E, Fargnoli MC, Longo C, Nazzaro G, Paoli J, Stanganelli I, Magi S, Lacarrubba F, Broganelli P, Perrot JL, Suppa M, Kittler H, Giuffrida R, Cinotti E, Sofia LC, Cataldo G, Cevenini G, Rubegni P
